Bryant Lim

Bryant Lim

Director of Finance/CFO bij PRELUDE THERAPEUTICS INCORPORATED

Vermogen: 24 342 $ op 30-04-2024

53 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Bryant D.
Lim
is currently the Director at Life Sciences Pennsylvania since 2019 and the Secretary, Chief Financial & Accounting Officer at Prelude Therapeutics, Inc. since 2023.
Previously, he worked as the Chief Compliance Officer & Vice President at Incyte Corp.
from 2014 to 2018.
He also held positions as Assistant Counsel at Merck & Co., Inc., Associate General Counsel at Viropharma, Inc., and Chief Business Officer, SVP & General Counsel at Aceragen, Inc. from 2022 to 2023.
From 2018 to 2022, he served as the Secretary, Senior VP & General Counsel at Idera Pharmaceuticals, Inc. Mr. Lim completed his undergraduate degree at Rochester Christian University and his graduate degree at Villanova University School of Law.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
19-07-2023 18 217 ( 0.22% ) 14 646 $ 31-07-2023
01-03-2024 2 400 ( 0.00% ) 9 696 $ 30-04-2024

Actieve functies van Bryant Lim

BedrijvenFunctieBegin
PRELUDE THERAPEUTICS INCORPORATED Director of Finance/CFO 08-04-2024
Director/Board Member 01-05-2019
Alle actieve functies van Bryant Lim

Eerdere bekende functies van Bryant Lim

BedrijvenFunctieEinde
ACERAGEN, INC. General Counsel 17-02-2023
General Counsel 01-10-2022
INCYTE CORPORATION Compliance Officer 01-09-2018
Viropharma, Inc. Corporate Officer/Principal -
MERCK & CO., INC. General Counsel -
Ervaring van Bryant Lim in detail bekijken

Opleiding van Bryant Lim

Rochester Christian University Undergraduate Degree
Villanova University School of Law Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Bryant Lim in detail bekijken

Connecties

95

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
INCYTE CORPORATION

Health Technology

MERCK & CO., INC.

Health Technology

PRELUDE THERAPEUTICS INCORPORATED

Health Technology

Bedrijven in privébezit4

Health Technology

Commercial Services

Viropharma, Inc.

Aceragen, Inc.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Bryant Lim